Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharmacol ; 976: 176660, 2024 Aug 05.
Article in English | MEDLINE | ID: mdl-38795756

ABSTRACT

Apigenin and baicalein are structurally related flavonoids that have been reported to have multiple pharmacological activities. The aim of this study was to investigate the protective effects and potential mechanisms of apigenin and baicalein in D-galactose-induced aging rats. First, apigenin and baicalein showed remarkable antioxidant activity and anti-glycation activity in vitro. Secondly, the protective effects of apigenin and baicalein on aging rats were investigated. We found that apigenin and baicalein supplementation significantly ameliorated aging-related changes such as declines in the spatial learning and memory and histopathological damage of the hippocampus and thoracic aorta. In addition, our data showed that apigenin and baicalein alleviated oxidative stress as illustrated by decreasing MDA level, increasing SOD activity and GSH level. Further data showed that they significantly reduced the accumulation of advanced glycation end products (AGEs), inhibited the expression of RAGE, down-regulated phosphorylated nuclear factor (p-NF-κB (p65)). Our results suggested that the protective effects of apigenin and baicalein on aging rats were at least partially related to the inhibition of AGEs/RAGE/NF-κB pathway and the improvement of oxidative damage. Overall, apigenin and baicalein showed almost equal anti-aging efficacy. Our results provided an experimental basis for the application of apigenin and baicalein to delay the aging process.


Subject(s)
Aging , Aorta, Thoracic , Apigenin , Flavanones , Galactose , Glycation End Products, Advanced , NF-kappa B , Oxidative Stress , Rats, Sprague-Dawley , Receptor for Advanced Glycation End Products , Signal Transduction , Animals , Receptor for Advanced Glycation End Products/metabolism , Glycation End Products, Advanced/metabolism , Flavanones/pharmacology , Flavanones/therapeutic use , Apigenin/pharmacology , Apigenin/therapeutic use , Aging/drug effects , Aging/metabolism , Male , NF-kappa B/metabolism , Rats , Signal Transduction/drug effects , Oxidative Stress/drug effects , Aorta, Thoracic/drug effects , Aorta, Thoracic/metabolism , Aorta, Thoracic/pathology , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/pathology , Cognitive Dysfunction/drug therapy , Cognitive Dysfunction/metabolism , Cognitive Dysfunction/chemically induced , Antioxidants/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...